Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3414 Target Snapshot

DNA polymerase catalytic subunit · SINGLE PROTEIN · Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5)

100Compounds
4Assays
1Approved Drugs
103.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P08546. Use UniProt P08546 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P08546 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA polymerase catalytic subunit as ChEMBL target CHEMBL3414, mapped to UniProt P08546. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA polymerase catalytic subunit
SINGLE PROTEIN · Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5)
As of 2026-09-14
ChEMBL target ID
CHEMBL3414
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P08546
DNA polymerase catalytic subunit
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA polymerase catalytic subunit is the right protein anchor across sources, using UniProt P08546 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA polymerase catalytic subunit
UniProt AccessionP08546
Component TypeProtein
Sequence Length1242 aa

DNA polymerase catalytic subunit

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA polymerase catalytic subunit, mapped to UniProt P08546. Sequence length is 1242 aa.

Mapped IDP08546
Review nameDNA polymerase catalytic subunit
OrganismHuman cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5)
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50103.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL395623 7.92 IC50 12.0 Preclinical
CHEMBL3099827 7.66 IC50 22.0 Preclinical
CHEMBL3099826 7.52 IC50 30.0 Preclinical
CHEMBL247955 7.46 IC50 35.0 Preclinical
CHEMBL248363 7.43 IC50 37.0 Preclinical
CHEMBL3099825 7.3 IC50 50.0 Preclinical
CHEMBL3983250 7.23 IC50 59.0 Preclinical
CHEMBL248161 7.21 IC50 61.0 Preclinical
CHEMBL3985859 7.21 IC50 62.0 Preclinical
CHEMBL247355 7.19 IC50 65.0 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
14
5.5
14
6.0
32
6.5
21
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

4
Total Assays
100
Tested Compounds
1
Assay Types
Binding — 4 assays, 100 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 100 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine